tiprankstipranks
Trending News
More News >
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF
US Market

RepliCel Life Sciences (REPCF) Financial Statements

Compare
22 Followers

RepliCel Life Sciences Financial Overview

RepliCel Life Sciences's market cap is currently $755.91K. The company's EPS TTM is $0; its P/E ratio is -0.13; RepliCel Life Sciences is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74K
Gross ProfitC$ 353.74KC$ 352.26KC$ 353.74KC$ 353.74KC$ 353.74K
Operating IncomeC$ -360.00KC$ -1.39MC$ -1.39MC$ -2.30MC$ -1.33M
EBITDAC$ -359.46KC$ -1.39MC$ -736.00KC$ -4.07MC$ -1.58M
Net IncomeC$ -97.29KC$ -312.00KC$ -743.00KC$ -4.07MC$ -1.58M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.81KC$ 76.41KC$ 430.27KC$ 238.44KC$ 51.61K
Total AssetsC$ 147.10KC$ 287.79KC$ 798.22KC$ 591.79KC$ 420.96K
Total DebtC$ 681.59KC$ 873.19KC$ 40.96KC$ 34.26KC$ 76.03K
Net DebtC$ 679.78KC$ 814.03KC$ -372.07KC$ -186.93KC$ 41.66K
Total LiabilitiesC$ 4.66MC$ 4.82MC$ 6.71MC$ 7.43MC$ 5.48M
Stockholders' EquityC$ -4.51MC$ -4.53MC$ -5.92MC$ -6.84MC$ -5.06M
Cash Flow
Free Cash FlowC$ -530.86KC$ -1.41MC$ -1.41MC$ -2.51MC$ -765.21K
Operating Cash FlowC$ -530.86KC$ -1.41MC$ -1.41MC$ -2.51MC$ -765.21K
Investing Cash FlowC$ 17.25KC$ 0.00C$ 0.00C$ 0.00C$ 11.50K
Financing Cash FlowC$ 456.25KC$ 1.06MC$ 1.60MC$ 2.70MC$ 764.14K
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History

RepliCel Life Sciences Debt to Assets

RepliCel Life Sciences Cash Flow

RepliCel Life Sciences Forecast EPS vs Actual EPS